Purchases and Sales Made in Q1 2023 in Cyclo Therapeutics, Inc. (CYTH)
This table provides information about the institutional ownership of Cyclo Therapeutics, Inc. (CYTH) during Q1 2023. The information is specifically focused on institutions that hold shares of Cyclo Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
18.5KNew |
$15.2K - $42K
|
18.5K
$14.1K
|
|
|
May 09, 2023
Q1 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
7.17K+ 149.8% |
$5.88K - $16.3K
|
12K
$9.08K
|
|
|
May 12, 2023
Q1 2023
|
Clear Street Markets LLC
|
BUY
|
- |
1.73KNew |
$1.41K - $3.92K
|
1.73K
$1.31K
|
|
|
May 12, 2023
Q1 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
10+ 0.43% |
$8.2 - $22.7
|
2.31K
$1.76K
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-1.17K- 41.64% |
$959 - $2.66K
|
1.64K
$1.25K
|
|
|
May 15, 2023
Q1 2023
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-327K- 35.16% |
$268K - $742K
|
603K
$458K
|